Meeting of Interested Parties (MIP)

Essential Medicines: Access

Essential Drugs and Medicines Policy: Annual Report 2002

WHO Traditional Medicine Strategy 2002-2005

The first global WHO Traditional Medicine Strategy.

Safety of Medicines

A guide to detecting and reporting adverse drug reactions Why health professionals need to take action

Safety Monitoring of Medicinal Products

Guidelines for setting up and running a Pharmacovigilance Centre

The Importance of Pharmacovigilance

Safety Monitoring of medicinal products

Pharmaceuticals: Restrictions in Use and Availability

National regulatory decisions and voluntary withdrawal of products by manufacturers on grounds of safety that were reported to WHO between mid-1993 and early 1999.

Network for Monitoring the Impact of Globalization and TRIPS on Access to Medicines

Meeting Report

WHO Policy Perspectives on Medicines

A series of leaflets (6-pager), including links for French and Spanish versions.

No.1: Medicines Strategy, December 2000
No.2: Traditional Medicine -- Growing needs and potential, May 2002
No.3: Globalization, TRIPS and Access to Pharmaceuticals, March 2001
No.4: The Selection of Essential Medicines, June 2002
No.5: Promoting Rational Use of Medicines: Core Components, September 2002
No.6: How to develop and implement a national drug policy, January 2003

MIP Presentations